Skip to main content

Advertisement

Table 5 Clinical decision making in anticoagulation

From: Education and practice gaps on atrial fibrillation and anticoagulation: a survey of cardiovascular nurses

Statement SD D N A SA Rating Count
n (%) n (%) n (%) n (%) n (%)
The risk of stroke versus the risk of bleeding is clearly articulated to patients when commencing anticoagulation for stroke prevention in AF 3 (6) 9 (17) 14 (26) 24 (44) 4 (7) 54
I am unsure whether to advocate for thromboprophylaxis or not when involved in team decisions 7 (13) 22 (41) 14 (26) 10 (19) 1 (2) 54
It’s difficult to decide where the benefits of thromboprophylaxis outweigh the risks of hemorrhage 3 (7) 27 (50) 10 (19) 14 (26) 0 (0) 54
I feel I do not know enough about the risk and benefits of different anticoagulants 5 (9) 30 (57) 4 (8) 12 (23) 2 (4) 53
I take time to understand my patients views on the risks and benefits of anticoagulation 0 (0) 7 (13) 10 (19) 31 (58) 6 (11) 54
Generally, my patients are well informed about the risks and benefits of anticoagulation at time of commencement 3 (6) 8 (15) 11 (20) 28 (52) 4 (7) 54
My patients receive comprehensive education about anticoagulation prior to discharge 2 (4) 5 (9) 10 (19) 26 (48) 11 (20) 54
I use the CHADS2 or CHA2DS2-VASc scores with patients to help risk stratify stroke risk in clinical practice 6 (12) 12 (23) 15 (29) 13 (25) 6 (12) 52
I use the HAS-BLED score with patients to help risk stratify bleeding risk in clinical practice 11 (22) 13 (26) 16 (31) 9 (18) 2 (4) 51
I use shared decision making with patients to explain the risks and benefits of anticoagulation for stroke prevention in AF 5 (9) 7 (13) 14 (26) 23 (43) 5 (9) 54